Source: Annual Congress 2004 - What's new in the treatment of sleep apnoea



Rating:

Share or cite this content

Citations should be made in the following way:
M. Hack (Oxford, United Kingdom). Implications of treatment for commercial drivers. Annual Congress 2004 - What's new in the treatment of sleep apnoea

Member's Comments

No comment yet.

Related content which might interest you: Implications and priorities for tobacco control in Europe Source: Annual Congress 2006 - Tobacco control in Europe: what are the priorities? Year: 2006 Implications for treatment with adolescent smokers Source: Eur Respir J 2001; 18: Suppl. 33, 168s Year: 2001 Universal use of face masks for success against COVID-19: evidence and implications for prevention policies Source: Eur Respir J, 55 (6) 2001260; 10.1183/13993003.01260-2020 Year: 2020 Implications and priorities of tobacco control in Belgium and Europe Source: Eur Respir Rev 2008; 17: 205-208 Year: 2008 Clinical implications and opportunities for new drug therapies Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Implications of the exposome for exposure science Source: ERS Research Seminar 2015 Year: 2015 Protecting healthcare workers from SARS-CoV-2 infection: practical indications Source: Eur Respir Rev, 29 (155) 200068; 10.1183/16000617.0068-2020 Year: 2020 Implications for everyday practice Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease Year: 2008 Investigating the drivers for COPD treatment decisions Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Therapeutic and management implications Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited Year: 2010 Evaluation of the effectiveness of three different therapeutics modalities for tobacco cessation Source: Eur Respir J 2005; 26: Suppl. 49, 390s Year: 2005 Evidence-based medicines for children: important implications for new therapies at all ages Source: Eur Respir J 2006; 28: 1069-1072 Year: 2006 Respiratory medicines for children: current evidence, unlicensed use and research priorities Source: Eur Respir J 2010; 35: 247-265 Year: 2010 Exposing tobacco industry interference in policy-making: the role of research and ERS Source: International Congress 2015 – Spanish/Portuguese Day: Tobacco control policies Year: 2015 Uses and abuses of home oxygen: the financial implications Source: Annual Congress 2008 - Rationale of self-education in asthma therapy Year: 2008 Population screening initiatives and future strategies Source: International Congress 2014 – Ceremony for the ERS COPD research Award 2014 - Symposium: Finding patients with COPD: how, when and where Year: 2014 Tactics of the tobacco industry: marketing of electronic cigarettes and heated tobacco, interference with scientists and examples of successful regulation Source: International Congress 2019 – E-cigarettes and heated tobacco: a blessing or a curse? The latest scientific update Year: 2019 Implementing smoking cessation strategies in primary health care in Russia: Opportunities and challenges Source: Annual Congress 2012 - Tobacco use and cessation Year: 2012 Overview of last 20 years of tobacco control activities in Romania: achievements and future challenges Source: Eur Respir J 2006; 28: Suppl. 50, 703s Year: 2006 New perspectives in PGD prevention and treatment Source: School Course 2012 - Lung Transplantation Year: 2012